P2X 7-receptor binding in new-onset and secondary progressive MS – a [¹¹C]SMW139 PET study.

Autor: Lehto, Jussi^1,2,3 (AUTHOR) juleht@utu.fi, Aarnio, Richard¹ (AUTHOR), Tuisku, Jouni¹ (AUTHOR), Sucksdorff, Marcus^1,2,4 (AUTHOR), Koivumäki, Esa Mikko¹ (AUTHOR), Nylund, Marjo^1,2,3,4 (AUTHOR), Helin, Semi¹ (AUTHOR), Rajander, Johan^1,5 (AUTHOR), Danon, Jonathan⁶ (AUTHOR), Gilchrist, Jayson⁶ (AUTHOR), Kassiou, Michael⁶ (AUTHOR), Oikonen, Vesa¹ (AUTHOR), Airas, Laura^1,2,3,4 (AUTHOR)

Publikováno v: EJNMMI Research. 12/5/2024, Vol. 14 Issue 1, p1-10. 10p.

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis.

Autor: Hänninen K; Neurocenter, Turku University Hospital, University of Turku, Turku, Finland., Viitala M; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; StellarQ Ltd., Turku, Finland., Paavilainen T; Medical Imaging Centre of Southwest Finland, Turku, Finland., Karhu JO; Medical Imaging Centre of Southwest Finland, Turku, Finland., Rinne J; Neurocenter, Turku University Hospital, University of Turku, Turku, Finland.; Turku PET Centre, University of Turku, Turku, Finland., Koikkalainen J; Combinostics Ltd., Tampere, Finland., Lötjönen J; Turku PET Centre, University of Turku, Turku, Finland., Soilu-Hänninen M; Neurocenter, Turku University Hospital, University of Turku, Turku, Finland.

Publikováno v: Frontiers in neurology [Front Neurol] 2020 Jul 15; Vol. 11, pp. 606. Date of Electronic Publication: 2020 Jul 15 (Print Publication: 2020).

Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism.

Autor: Zedde, Marialuisa¹ (AUTHOR) valzania.franco@ausl.re.it, Romani, Ilaria² (AUTHOR) ilaria.romani1@gmail.com, Scaravilli, Alessandra³ (AUTHOR) alessandra.scaravilli@gmail.com, Cocozza, Sirio³ (AUTHOR) sirio.cocozza@unina.it, Trojano, Luigi⁴ (AUTHOR) luigi.trojano@unicampania.it, Ragno, Michele⁵ (AUTHOR) ragno.neuro@gmail.com, Rifino, Nicola⁶ (AUTHOR) nicola.rifino@istituto-besta.it, Bersano, Anna⁶ (AUTHOR) anna.bersano@istituto-besta.it, Gerevini, Simonetta⁷ (AUTHOR) sgerevini@asst-pg23.it, Pantoni, Leonardo⁸ (AUTHOR) leonardo.pantoni@unimi.it, Valzania, Franco¹ (AUTHOR), Pascarella, Rosario⁹ (AUTHOR) pascarella.rosario@ausl.re.it

Publikováno v: Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1131. 29p.

Microglial activation, white matter tract damage, and disability in MS.

Autor: Rissanen E; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Tuisku J; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Vahlberg T; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Sucksdorff M; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Paavilainen T; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Parkkola R; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Rokka J; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Gerhard A; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Hinz R; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Talbot PS; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Rinne JO; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom., Airas L; Turku PET Centre (E.R., J.T., M.S., J.R., J.O.R.), Division of Clinical Neurosciences (E.R., M.S., J.O.R., L.A.), Department of Biostatistics (T.V.), and Medical Imaging Centre of Southwest Finland (T.P., R.P.), Turku University Hospital and University of Turku, Finland; Division of Neuroscience and Experimental Psychology (A.G.), University of Manchester, United Kingdom; Department of Nuclear Medicine and Geriatric Medicine (A.G.), University Hospital Essen, Germany; and Wolfson Molecular Imaging Centre (R.H., P.S.T.), University of Manchester, United Kingdom.

Publikováno v: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2018 Mar 06; Vol. 5 (3), pp. e443. Date of Electronic Publication: 2018 Mar 06 (Print Publication: 2018).

Cementless total hip arthroplasty in patients with severely dysplastic hips and a previous Schanz osteotomy of the femur: techniques, pitfalls, and long-term outcome.

Autor: Eskelinen A, Remes V, Ylinen P, Helenius I, Tallroth K, Paavilainen T

Publikováno v: Acta Orthopaedica; Jun2009, Vol. 80 Issue 3, p263-269, 7p